Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

CORVEL CORP Director's Dealing 2024

Feb 6, 2024

31179_dirs_2024-02-05_203ad15b-2c25-4e7c-8484-af032fc83611.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: CORVEL CORP (CRVL)
CIK: 0000874866
Period of Report: 2024-02-05

Reporting Person: Combs Michael G (CEO & President)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2024-02-05 Common Stock M 6000 $87.69 Acquired 19846 Direct
2024-02-05 Common Stock F 2240 $234.85 Disposed 17606 Direct
2024-02-05 Common Stock F 1855 $234.85 Disposed 15751 Direct
2024-02-05 Common Stock M 4500 $87.69 Acquired 20251 Direct
2024-02-05 Common Stock F 1680 $234.85 Disposed 18571 Direct
2024-02-05 Common Stock F 1391 $234.85 Disposed 17180 Direct
2024-02-05 Common Stock M 4500 $87.69 Acquired 21680 Direct
2024-02-05 Common Stock F 1680 $234.85 Disposed 20000 Direct
2024-02-05 Common Stock F 1391 $234.85 Disposed 18609 Direct
2024-02-05 Common Stock M 5600 $52.69 Acquired 24209 Direct
2024-02-05 Common Stock F 1256 $234.85 Disposed 22953 Direct
2024-02-05 Common Stock F 1570 $234.85 Disposed 21383 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2024-02-05 Non-Qualified Stock Option (right to buy) $52.69 M 5600 Disposed 2025-04-30 Common Stock (5600) Direct
2024-02-05 Non-Qualified Stock Option (right to buy) $87.69 M 6000 Disposed 2025-11-05 Common Stock (6000) Direct
2024-02-05 Non-Qualified Stock Option (right to buy) $87.69 M 4500 Disposed 2025-11-05 Common Stock (4500) Direct
2024-02-05 Non-Qualified Stock Option (right to buy) $87.69 M 4500 Disposed 2025-11-05 Common Stock (4500) Direct

Footnotes

F1: Shares delivered in payment of the option exercise price and/or tax liability incident to the option exercise.

F2: Exercisable as to 25% of shares one year following grant date with the remaining shares exercisable in 36 equal monthly installments thereafter.

F3: Option will vest based on achievement of certain performance criteria relating to earnings growth.